Fritextsökning
-
“What is important is to create an overview and understanding from different perspectives”
Scientist Jochen Schwenk analyses blood proteins using proteomics to improve our understanding of disease and health. This year, he is moderating the Lab & Diag...
-
Scientific Solutions
-
Pfizer påbörjar vaccinprogram mot influensa
Pfizer har rekryterat den första patienten för sin mRNA-baserade vaccinstudie mot influensa.
-
17 nätdroger narkotikaklassas
Vissa har orsakat dödsfall.
-
Business Sweden: “Companies have a lot to offer in data-driven precision medicine”
Data-driven precision medicine can potentially solve major healthcare problems, states Business Sweden in a new report on the subject.
-
Hett i tanken
Synglas från KSR Kuebler förenklar nivåövervakningen
-
New report: Fewer PhDs in life sciences
A new report from Vinnova suggests that competency returns in the life science sector are declining.
-
Novo Nordisks insulin gav bättre kontroll
Signifikant bättre blodsockerkontroll och lägre risk för hypoglykemi med bolagets långverkande insulin jämfört med konkurrerande preparat. Detta visar data från...
-
Biomarkörer kan avgöra svårighetsgrad av astma
Forskare från Karolinska institutet har genom att studera urinprov kunnat diagnosticera svår astma.
-
Nobel Prize winner Torsten Wiesel turns 100: “Old men like me should use their experience to help the young”
In 1955, a young Torsten Wiesel jumped on a boat to the US and embarked on a fabulous career as a neuroscientist, crowned with a Nobel Prize for his work. Now 1...
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
“We aim to be a start-up company with an academic spirit”
Chronic pain and Alzheimer’s are two diseases that plague many people worldwide and seem impossible to cure. However, Huddinge-based company Alzecure is working...
-
Gileads besked – så mycket kommer remdesivir kosta
Priset för att behandla en covid-19-patient med remdesvir landar på 21 800 kronor. – Det är lite lägre än vad jag trodde, säger Anders Sönnerborg till Life Science Sweden.
-
Så tog vi oss in på USA-marknaden
Här delar Nikolaj Sørensen, vd och koncernchef, med sig av Orexos tuffa resa att lansera läkemedel i USA.
-
Bayer skär ned kraftigt
Den tyska kemijätten ska omstrukturera läkemedelsforskningen och konsumenthälsodelen av bolaget och skär ned med 900 tjänster.
-
We will now publish more news in English – and offer yet another newsletter
Starting next week, Life Science Sweden will begin offering a newsletter entirely in English.
-
Now it’s settled: The International Vaccine Institute will be located in Stockholm
The International Vaccine Institute, IVI, is establishing itself outside South Korea for the first time. Last week, the Swedish Parliament ratified the agreemen...
-
Collaboration for a simpler production of gene therapies launched
A collaboration between universities and companies aims at providing better production methods for the development of gene therapies. The initiative is led by J...
-
De tar plats i Sobis styrelse
David Allsop och Elisabeth Svanberg nya ledamöter i läkemedelsbolagets styrelse.
-
The TFS family is growing
TFS HealthScience is a European based CRO company with broad expertise and experiences in the biotech and pharmaceutical sector. The company is growing and the ...
-
Amorphous materials take centre stage when Orexo develops new formulations
Swift resolution but with maintained stability. Orexo’s new drug delivery platform tackles the problem of amorphous materials. “Our technology has the positive ...
-
Ågerup ger bort rubbet
Skänker sin förmögenhet till utvecklingsprojekt i u-länder.
-
Godishalsband inspirerade till ny läkemedelsteknik
En spiral med medicintabletter som ligger i patientens mage under en längre period och utsöndrar läkemedel under tiden – det kan vara nyckeln till att människor...
-
Top modern lab to Sahlgrenska
The Sahlgrenska Science Park will soon open the doors to a brand new wet laboratory.